156 related articles for article (PubMed ID: 26432623)
1. Sliding Scale Insulin vs Basal-Bolus Insulin Therapy in Long-Term Care: A 21-Day Randomized Controlled Trial Comparing Efficacy, Safety and Feasibility.
Dharmarajan TS; Mahajan D; Zambrano A; Agarwal B; Fischer R; Sheikh Z; Skokowska-Lebelt A; Patel M; Wester R; Madireddy NP; Pandya N; Baralatei FT; Vance J; Norkus EP
J Am Med Dir Assoc; 2016 Mar; 17(3):206-13. PubMed ID: 26432623
[TBL] [Abstract][Full Text] [Related]
2. A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Patients With Type 2 Diabetes in Long-term Care and Skilled Nursing Facilities: Linagliptin-LTC Trial.
Umpierrez GE; Cardona S; Chachkhiani D; Fayfman M; Saiyed S; Wang H; Vellanki P; Haw JS; Olson DE; Pasquel FJ; Johnson TM
J Am Med Dir Assoc; 2018 May; 19(5):399-404.e3. PubMed ID: 29289540
[TBL] [Abstract][Full Text] [Related]
3. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial).
Umpierrez GE; Smiley D; Zisman A; Prieto LM; Palacio A; Ceron M; Puig A; Mejia R
Diabetes Care; 2007 Sep; 30(9):2181-6. PubMed ID: 17513708
[TBL] [Abstract][Full Text] [Related]
4. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery).
Umpierrez GE; Smiley D; Jacobs S; Peng L; Temponi A; Mulligan P; Umpierrez D; Newton C; Olson D; Rizzo M
Diabetes Care; 2011 Feb; 34(2):256-61. PubMed ID: 21228246
[TBL] [Abstract][Full Text] [Related]
5. Insulin glargine dosing before next-day surgery: comparing three strategies.
Rosenblatt SI; Dukatz T; Jahn R; Ramsdell C; Sakharova A; Henry M; Arndt-Mutz M; Miller V; Rogers K; Balasubramaniam M
J Clin Anesth; 2012 Dec; 24(8):610-7. PubMed ID: 23122972
[TBL] [Abstract][Full Text] [Related]
6. Burden of sliding scale insulin use in elderly long-term care residents with type 2 diabetes mellitus.
Pandya N; Wei W; Meyers JL; Kilpatrick BS; Davis KL
J Am Geriatr Soc; 2013 Dec; 61(12):2103-2110. PubMed ID: 24479142
[TBL] [Abstract][Full Text] [Related]
7. Randomized study comparing a Basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial.
Umpierrez GE; Smiley D; Hermayer K; Khan A; Olson DE; Newton C; Jacobs S; Rizzo M; Peng L; Reyes D; Pinzon I; Fereira ME; Hunt V; Gore A; Toyoshima MT; Fonseca VA
Diabetes Care; 2013 Aug; 36(8):2169-74. PubMed ID: 23435159
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, quality of care, and complications in long term care residents with diabetes: a multicenter observational study.
Newton CA; Adeel S; Sadeghi-Yarandi S; Powell W; Migdal A; Smiley D; Olson D; Chambria R; Pinzon I; Toyoshima M; Nagamia Z; Peng L; Johnson T; Umpierrez GE
J Am Med Dir Assoc; 2013 Nov; 14(11):842-6. PubMed ID: 24055534
[TBL] [Abstract][Full Text] [Related]
9. The prevalence and persistence of sliding scale insulin use among newly admitted elderly nursing home residents with diabetes mellitus.
Pandya N; Thompson S; Sambamoorthi U
J Am Med Dir Assoc; 2008 Nov; 9(9):663-9. PubMed ID: 18992699
[TBL] [Abstract][Full Text] [Related]
10. Biphasic insulin aspart given thrice daily is as efficacious as a basal-bolus insulin regimen with four daily injections: a randomised open-label parallel group four months comparison in patients with type 2 diabetes.
Ligthelm RJ; Mouritzen U; Lynggaard H; Landin-Olsson M; Fox C; le Devehat C; Romero E; Liebl A
Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):511-9. PubMed ID: 17115349
[TBL] [Abstract][Full Text] [Related]
11. Randomized controlled trial of insulin supplementation for correction of bedtime hyperglycemia in hospitalized patients with type 2 diabetes.
Vellanki P; Bean R; Oyedokun FA; Pasquel FJ; Smiley D; Farrokhi F; Newton C; Peng L; Umpierrez GE
Diabetes Care; 2015 Apr; 38(4):568-74. PubMed ID: 25665812
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of basal-bolus insulin regimens in the inpatient management of non-critically ill patients with type 2 diabetes: A systematic review and meta-analysis.
Christensen MB; Gotfredsen A; Nørgaard K
Diabetes Metab Res Rev; 2017 Jul; 33(5):. PubMed ID: 28067472
[TBL] [Abstract][Full Text] [Related]
13. Management of hyperglycemia in diabetic patients with hematologic malignancies during dexamethasone therapy.
Gosmanov AR; Goorha S; Stelts S; Peng L; Umpierrez GE
Endocr Pract; 2013; 19(2):231-5. PubMed ID: 23337144
[TBL] [Abstract][Full Text] [Related]
14. Switching to basal-bolus insulin therapy is effective and safe in long-term type 2 diabetes patients inadequately controlled with other insulin regimens.
Vinagre I; Sánchez-Hernández J; Sánchez-Quesada JL; María MÁ; de Leiva A; Pérez A
Endocrinol Nutr; 2013 May; 60(5):249-53. PubMed ID: 23523346
[TBL] [Abstract][Full Text] [Related]
15. Basal-bolus insulin versus sliding-scale insulin for inpatient glycaemic control: a clinical practice comparison.
Roberts GW; Aguilar-Loza N; Esterman A; Burt MG; Stranks SN
Med J Aust; 2012 Mar; 196(4):266-9. PubMed ID: 22409694
[TBL] [Abstract][Full Text] [Related]
16. Safety of once-daily insulin detemir in patients with type 2 diabetes treated with oral hypoglycemic agents in routine clinical practice.
Ross S; Dzida G; Ji Q; Kaiser M; Ligthelm R; Meneghini L; Nazeri A; Orozco-Beltran D; Pan C; Svendsen AL;
J Diabetes; 2014 May; 6(3):243-50. PubMed ID: 24103141
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Intensive Versus Nonintensive Supplemental Insulin With a Basal-Bolus Insulin Regimen in Hospitalized Patients With Type 2 Diabetes: A Randomized Clinical Study.
Vellanki P; Cardona S; Galindo RJ; Urrutia MA; Pasquel FJ; Davis GM; Fayfman M; Migdal A; Peng L; Umpierrez GE
Diabetes Care; 2022 Oct; 45(10):2217-2223. PubMed ID: 35675498
[TBL] [Abstract][Full Text] [Related]
18. Insulin therapy in type 2 diabetes: what is the evidence?
van Avendonk MJ; Rutten GE
Diabetes Obes Metab; 2009 May; 11(5):415-32. PubMed ID: 19175375
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for inpatient hypoglycemia during subcutaneous insulin therapy in non-critically ill patients with type 2 diabetes.
Farrokhi F; Klindukhova O; Chandra P; Peng L; Smiley D; Newton C; Pasquel F; Fereira ME; Umpierrez G
J Diabetes Sci Technol; 2012 Sep; 6(5):1022-9. PubMed ID: 23063027
[TBL] [Abstract][Full Text] [Related]
20. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
